BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15108017)

  • 1. Quantitative dynamic contrast-enhanced sonography of hepatic tumors.
    Klein D; Jenett M; Gassel HJ; Sandstede J; Hahn D
    Eur Radiol; 2004 Jun; 14(6):1082-91. PubMed ID: 15108017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
    Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
    J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.
    von Herbay A; Vogt C; Willers R; Häussinger D
    J Ultrasound Med; 2004 Dec; 23(12):1557-68. PubMed ID: 15557299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography.
    Kim TK; Jang HJ; Burns PN; Murphy-Lavallee J; Wilson SR
    AJR Am J Roentgenol; 2008 Jan; 190(1):58-66. PubMed ID: 18094294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
    Denis de Senneville B; Frulio N; Laumonier H; Salut C; Lafitte L; Trillaud H
    Eur Radiol; 2020 May; 30(5):2995-3003. PubMed ID: 32002637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
    Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
    Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced ultrasonography parameters in neural network diagnosis of liver tumors.
    Streba CT; Ionescu M; Gheonea DI; Sandulescu L; Ciurea T; Saftoiu A; Vere CC; Rogoveanu I
    World J Gastroenterol; 2012 Aug; 18(32):4427-34. PubMed ID: 22969209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis.
    Kim SH; Lee JM; Lee JY; Han JK; An SK; Han CJ; Lee KH; Hwang SS; Choi BI
    AJR Am J Roentgenol; 2005 Apr; 184(4):1077-84. PubMed ID: 15788576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: a prospective controlled two-center study.
    Jung EM; Clevert DA; Schreyer AG; Schmitt S; Rennert J; Kubale R; Feuerbach S; Jung F
    World J Gastroenterol; 2007 Dec; 13(47):6356-64. PubMed ID: 18081224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced agent detection imaging: value in the characterization of focal hepatic lesions.
    Youk JH; Kim CS; Lee JM
    J Ultrasound Med; 2003 Sep; 22(9):897-910. PubMed ID: 14510261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced ultrasound in diagnosing liver malignancy.
    Zuber-Jerger I; Schacherer D; Woenckhaus M; Jung EM; Schölmerich J; Klebl F
    Clin Hemorheol Microcirc; 2009; 43(1-2):109-18. PubMed ID: 19713605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation between benign and malignant hepatic lesions: utility of color stimulated acoustic emission with the microbubble contrast agent Levovist.
    von Herbay A; Vogt C; Häussinger D
    J Ultrasound Med; 2004 Feb; 23(2):207-15. PubMed ID: 14992357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Liver Tumors by Diffusion-Weighted Imaging: Comparison of Diagnostic Performance Using the Mean and Minimum Apparent Diffusion Coefficient.
    Namimoto T; Nakagawa M; Kizaki Y; Itatani R; Kidoh M; Utsunomiya D; Oda S; Yamashita Y
    J Comput Assist Tomogr; 2015; 39(4):453-61. PubMed ID: 25836022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parametric imaging with contrast-enhanced ultrasound: usefulness for characterization of dynamic effects of microvascularization for hepatocellular carcinoma and focal nodular hyperplasia.
    Zheng SG; Xu HX; Liu LN; Wang Y; Zhang YF; Guo LH; Liu C; Xu JM; Sun LP; Wu J
    Clin Hemorheol Microcirc; 2013; 55(3):375-89. PubMed ID: 23271200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy and interobserver variability of Dynamic Vascular Pattern (DVP) in primary liver malignancies - A simple semiquantitative tool for the analysis of contrast enhancement patterns.
    Schellhaas B; Waldner MJ; Görtz RS; Vitali F; Kielisch C; Pfeifer L; Strobel D; Janka R; Neurath MF; Wildner D
    Clin Hemorheol Microcirc; 2017; 66(4):317-331. PubMed ID: 28211805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
    Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
    Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.